Personal CFO Solutions’s Adaptimmune Therapeutics ADAP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-19,388
| Closed | -$17.9K | – | 456 |
|
|
2023
Q2 | $17.9K | Hold |
19,388
| – | – | ﹤0.01% | 466 |
|
|
2023
Q1 | $21.1K | Hold |
19,388
| – | – | ﹤0.01% | 467 |
|
|
2022
Q4 | $28.3K | Hold |
19,388
| – | – | 0.01% | 451 |
|
|
2022
Q3 | $21K | Sell |
19,388
-3,000
| -13% | -$3.25K | 0.01% | 409 |
|
|
2022
Q2 | $38K | Sell |
22,388
-4,000
| -15% | -$6.79K | 0.01% | 423 |
|
|
2022
Q1 | $54K | Hold |
26,388
| – | – | 0.01% | 458 |
|
|
2021
Q4 | $99K | Sell |
26,388
-10,000
| -27% | -$37.5K | 0.02% | 461 |
|
|
2021
Q3 | $188K | Buy |
36,388
+6,000
| +20% | +$31K | 0.04% | 423 |
|
|
2021
Q2 | $129K | Buy |
30,388
+16,500
| +119% | +$70K | 0.03% | 417 |
|
|
2021
Q1 | $74K | Buy |
13,888
+2,000
| +17% | +$10.7K | 0.02% | 397 |
|
|
2020
Q4 | $64K | Sell |
11,888
-13,909
| -54% | -$74.9K | 0.02% | 366 |
|
|
2020
Q3 | $0 | Buy |
+25,797
| New | – | ﹤0.01% | 137 |
|